The Medicines Company (MDCO) Additional Phase 2 Data Confirms Market Potential - Guggenheim
Go back to The Medicines Company (MDCO) Additional Phase 2 Data Confirms Market Potential - GuggenheimMedicines Co (NASDAQ: MDCO) | Delayed: 84.90 --0 (-0%) | |||||
---|---|---|---|---|---|---|
Previous Close | $84.90 | 52 Week High | $43.00 | |||
Open | $3.15 | 52 Week Low | $27.50 | |||
Day High | $84.90 | P/E | 339.60 | |||
Day Low | $84.90 | EPS | $0.25 | |||
Volume | 413,822 |